Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06211348 · ClinicalTrials.gov registry record · NA

Genomic Sequencing in Anatomically Normal Fetuses

A NA study of Pregnant Individuals Requesting Standard Microarray, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT06211348 is a NA study of Pregnant Individuals Requesting Standard Microarray that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06211348, a NA study of Pregnant Individuals Requesting Standard Microarray, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

This cohort study will examine the clinical utility of genomic sequencing (GS) in patients undergoing prenatal diagnostic procedures (chorionic villus sampling or amniocentesis) for routine indications other than a structural fetal anomaly.

Interventions

  • DEVICE Genomic Sequencing

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2024-01-01
Est. Completion 2030-01
Phase NA

What the Registry Record Tells You About NCT06211348

The ClinicalTrials.gov registry entry for NCT06211348 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pregnant Individuals Requesting Standard Microarray appearing as the primary indexed condition, and to 1 intervention - of which Genomic Sequencing is the first listed.

NCT06211348 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06211348 about?

NCT06211348 is a clinical study titled "Genomic Sequencing in Anatomically Normal Fetuses". This cohort study will examine the clinical utility of genomic sequencing (GS) in patients undergoing prenatal diagnostic procedures (chorionic villus sampling or amniocentesis) for routine indications other than a structural fetal anomaly.

What is the current status of trial NCT06211348?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2024-01-01. Estimated completion is 2030-01.

What conditions does trial NCT06211348 study?

This clinical trial studies the following conditions: Pregnant Individuals Requesting Standard Microarray.

What interventions are being tested in trial NCT06211348?

The interventions under investigation include: Genomic Sequencing (DEVICE).

Who is sponsoring clinical trial NCT06211348?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06211348 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.